Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06533410 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Using the Chinese Indigenization FS Scale in the Diagnosis of Fibromyalgia： Specificity and Sensitivity in Clinical Practice

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 21, 2024 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Enrollment target: 90 to 59
    • Secondary endpoints: details revised at 6 of 6 entries
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aimed to evaluate the specificity and sensitivity of the diagnostic criteria for fibromyalgia after conducting local validation in China.
Trial Details
NCT Number NCT06533410
Lead Sponsor Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Collaborators: Hebei Provincial Hospital of Traditional Chinese Medicine, BAODING NO.1 HOSPITAL OF TCM, Inner Mongolia Hospital of Traditional Chinese Medicine, Shenzhen Hospital of Traditional Chinese Medicine, Suzhou Hospital of Traditional Chinese Medicine
Conditions
(from sponsor)		 Fibromyalgia
Related terms Fibromyalgia
Enrollment 59 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov